HCAP not busy being born is busy dying

American Journal of Respiratory and Critical Care Medicine

Volumn 189, Issue 3, 2014, Pages 365-366

  Ewig, Santiago ^a  

^a Thoraxzentrum Ruhrgebiet   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTACID AGENT; ANTIBIOTIC AGENT;

ADVERSE OUTCOME; ANTIBIOTIC THERAPY; ANTIMICROBIAL THERAPY; COMMUNITY ACQUIRED PNEUMONIA; COMORBIDITY; DYING; ENTERIC FEEDING; EXTERNAL VALIDITY; HOSPITALIZATION; HUMAN; IMMOBILITY; IMMUNOSUPPRESSIVE TREATMENT; INFECTION RISK; LETTER; MORTALITY; MULTIDRUG RESISTANCE; PNEUMONIA; PRACTICE GUIDELINE; PREDICTIVE VALUE; PRIORITY JOURNAL;

BACTERIA; COMMUNITY-ACQUIRED INFECTIONS; CROSS INFECTION; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FEMALE; HOSPITALIZATION; HUMANS; INTENSIVE CARE UNITS; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; PNEUMONIA; PNEUMONIA, BACTERIAL; PSEUDOMONAS AERUGINOSA; RISK ASSESSMENT;

EID: 84893557206     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.201307-1383LE     Document Type: Letter

References (4)

1. Shindo Y, Ito R, Kobayashi D, Ando M, Ichikawa M, Shiraki A, Goto Y, Fukui Y, Iwaki M, Okumura J, et al.; Central Japan Lung Study Group. Risk factors for drug-resistant pathogens in community-acquired and healthcare-associated pneumonia. Am J Respir Crit Care Med 2013;188:985-995.
2. Shorr AF, Zilberberg MD, Reichley R, Kan J, Hoban A, Hoffman J, Micek ST, Kollef MH. Validation of a clinical score for assessing the risk of resistant pathogens in patients with pneumonia presenting to the emergency department. Clin Infect Dis 2012;54:193-198.
3. Aliberti S, Cilloniz C, Chalmers JD, Zanaboni AM, Cosentini R, Tarsia P, Pesci A, Blasi F, Torres A. Multidrug-resistant pathogens in hospitalised patients coming from the community with pneumonia: a European perspective. Thorax 2013;68:997-999.
4. Ewig S, Welte T, Chastre J, Torres A. Rethinking the concepts of community-acquired and health-care-associated pneumonia. Lancet Infect Dis 2010;10:279-287.